CLINICAL_TRIALS
trial_result
· 2022-01-21
Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis [Phase 2]
Summary
A Phase 2 trial evaluating filgotinib for active noninfectious uveitis was terminated; results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: Noninfectious Uveitis | Phase 2 | Status: TERMINATED | Results posted: 2022-01-21